Clarity Pharmaceuticals Ltd (ASX: CU6)
Australia flag Australia · Delayed Price · Currency is AUD
5.97
-0.09 (-1.49%)
Nov 21, 2024, 4:10 PM AEST

Clarity Pharmaceuticals Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Jun '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019 - 2018
Other Revenue
11.5111.519.86.463.22.79
Upgrade
Revenue
11.5111.519.86.463.22.79
Upgrade
Revenue Growth (YoY)
17.41%17.41%51.74%102.06%14.62%5.50%
Upgrade
Gross Profit
11.5111.519.86.463.22.79
Upgrade
Selling, General & Admin
10.5210.524.714.613.832.82
Upgrade
Research & Development
45.7845.7831.4618.99.687.03
Upgrade
Operating Expenses
56.3156.3136.1623.5113.519.85
Upgrade
Operating Income
-44.8-44.8-26.36-17.05-10.31-7.06
Upgrade
Interest Expense
------0.01
Upgrade
Interest & Investment Income
2.772.771.860.10.040.06
Upgrade
EBT Excluding Unusual Items
-42.03-42.03-24.5-16.95-10.27-7
Upgrade
Other Unusual Items
----6.780.050.05
Upgrade
Pretax Income
-42.03-42.03-24.5-23.74-10.22-6.95
Upgrade
Income Tax Expense
0.30.30.10.02--
Upgrade
Net Income
-42.32-42.32-24.6-23.75-10.22-6.95
Upgrade
Net Income to Common
-42.32-42.32-24.6-23.75-10.22-6.95
Upgrade
Shares Outstanding (Basic)
273273260248176146
Upgrade
Shares Outstanding (Diluted)
273273260248176146
Upgrade
Shares Change (YoY)
5.22%5.22%4.81%40.37%20.54%2.86%
Upgrade
EPS (Basic)
-0.15-0.15-0.09-0.10-0.06-0.05
Upgrade
EPS (Diluted)
-0.15-0.15-0.10-0.10-0.06-0.05
Upgrade
Free Cash Flow
-43.74-43.74-27.55-13.53-7.74-6.84
Upgrade
Free Cash Flow Per Share
-0.16-0.16-0.11-0.05-0.04-0.05
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-389.35%-389.35%-269.00%-263.94%-322.65%-253.06%
Upgrade
Profit Margin
-367.83%-367.83%-251.03%-367.78%-319.77%-249.35%
Upgrade
Free Cash Flow Margin
-380.14%-380.14%-281.07%-209.43%-242.06%-245.44%
Upgrade
EBITDA
-44.65-44.65-26.26-17-10.3-7.04
Upgrade
EBITDA Margin
---267.97%-263.22%--252.45%
Upgrade
D&A For EBITDA
0.150.150.10.050.020.02
Upgrade
EBIT
-44.8-44.8-26.36-17.05-10.31-7.06
Upgrade
EBIT Margin
---269.00%-263.94%--253.06%
Upgrade
Revenue as Reported
14.2814.2811.666.553.292.9
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.